Hemab Therapeutics
PublicLast Round
IPO Announced
May 1, 2026
Est. Valuation
$795.47M
Total Funding Raised
$853.66M
Company Overview
Hemab Therapeutics is a biotechnology company that develops prophylactic therapeutics aimed at treating bleeding and thrombosis disorders by enhancing the body's natural clotting mechanisms to prevent life-threatening complications.
Sector
Biotech
Verticals
Digital Health, HealthTech, Life Sciences
AI Layer
Non-AI
Keywords
biotechnologymonoclonal antibodybleeding disordersrare diseaseclinical-stage biotechbispecific antibodyGlanzmann Thrombastheniablood coagulationprophylactic therapeuticsclinical trialsdrug developmentorphan drugbiopharmahematologypipeline assets
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemab Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Hemab Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | May 1, 2026 | ||||
| Series C | Oct 27, 2025 | ||||
| Series C | Oct 27, 2023 | ||||
| Series B | Feb 16, 2023 | ||||
| Series A | Jul 22, 2021 | ||||
Seed | Dec 14, 2020 |
Key People
Founding team and executive leadership
Hemab Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Access Industries | Series B |
| Evercore ISI | IPO |
| Maj Invest Equity A/S | Series B, Series C |
| RA Capital Management | Series C, Series B, Series A |
| Avoro Ventures | Series C, Series B |
| Avoro Capital | Series B |
Hemab Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersCopenhagen, Capital Region of Denmark
Employee Range91
Year Founded2019
Last FundingMay 1, 2026
